These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6760356)

  • 21. Treatment strategies of hamster-to-rat cardiac xenotransplantation.
    Steinbrüchel DA; Nielsen B; Kemp E
    Transplant Proc; 1994 Apr; 26(2):1039-41. PubMed ID: 8171460
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of humoral rejection after heart transplantation.
    Grauhan O; Müller J; v Baeyer H; Volk HD; Fietze E; Cohnert T; Meyer R; Pfitzmann R; Mansfeld H; Siniawski H; Warnecke H; Hetzer R
    J Heart Lung Transplant; 1998 Dec; 17(12):1184-94. PubMed ID: 9883759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac xenotransplantation: insurmountable barrier or clinical reality?
    Michler RE; Chen JM; Rose EA
    Adv Card Surg; 1994; 5():231-44. PubMed ID: 8118594
    [No Abstract]   [Full Text] [Related]  

  • 24. The pediatric heart transplant patient: immunosuppressive drugs and organ rejection.
    Schnepf CA
    J Pediatr Health Care; 1987; 1(2):91-7. PubMed ID: 3320330
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac transplantation: update.
    Futterman LG; Lemberg L
    Am J Crit Care; 1992 Sep; 1(2):118-20. PubMed ID: 1307886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary excretion of acetylated polyamines after heart transplantation in dogs].
    Thai P; Carrier M; Pelletier LC
    Ann Chir; 1994; 48(8):742-8. PubMed ID: 7872624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart transplantation in closely related species: a model for humoral rejection.
    Ertel W; Reichenspurner H; Hammer C; Welz A; Uberfuhr P; Hemmer W; Reichart B; Gokel M; Brendel W
    Transplant Proc; 1984 Oct; 16(5):1259-61. PubMed ID: 6385390
    [No Abstract]   [Full Text] [Related]  

  • 29. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trends in cardiac transplantation.
    Klein DG
    Crit Care Nurs Clin North Am; 2007 Dec; 19(4):445-60, vii. PubMed ID: 18022529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A.
    Brünisholz MC; Bailey RR
    N Z Med J; 1985 Nov; 98(790):948-50. PubMed ID: 3909019
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin A in organ transplantation.
    Calne RY; Rolles K; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Henderson RG; Aziz S; Lewis P
    Adv Nephrol Necker Hosp; 1981; 10():335-47. PubMed ID: 6791475
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heart transplantation].
    Aris A
    Rev Clin Esp; 1986 Nov; 179(7):373-7. PubMed ID: 3541080
    [No Abstract]   [Full Text] [Related]  

  • 34. Heart transplantation, the Tucson perspective.
    Copeland JG
    J Heart Transplant; 1985; 4(5):499-501. PubMed ID: 3916526
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
    Aharoni R; Yussim A; Sela M; Arnon R
    Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of beneficial blood transfusion effect in dogs is dependent upon immunosuppressants used.
    Niessen GJ; Obertop H; Bijnen AB; Marquet RL; Jeekel J
    Transplant Proc; 1982 Jun; 14(2):400-2. PubMed ID: 7051486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac transplantation: role of endomyocardial biopsy and immunosuppressive agents.
    Eiswirth CC; Smart FW
    J La State Med Soc; 1993 May; 145(5):203-6. PubMed ID: 8340682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 40. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.
    Uber PA; Ross HJ; Zuckermann AO; Sweet SC; Corris PA; McNeil K; Mehra MR
    J Heart Lung Transplant; 2009 Jul; 28(7):655-60. PubMed ID: 19560691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.